Christopher R. Fenimore, VP Controller at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,970 shares at $488.76 ($963K) on 2020-04-01, disclosed to the SEC on 2020-04-03.
Open-market sale of $963k REGN by VP Controller. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $478.77 | 63 | $30K | 3.1% |
| 2 | $479.00 | 69 | $33K | 3.4% |
| 3 | $480.28 | 58 | $28K | 2.9% |
| 4 | $482.09 | 62 | $30K | 3.1% |
| 5 | $483.58 | 124 | $60K | 6.2% |
| 6 | $483.58 | 124 |
| $60K |
| 6.2% |
| 7 | $484.14 | 3 | $1K | 0.2% |
| 8 | $488.76 | 137 | $67K | 7.0% |
| 9 | $488.76 | 137 | $67K | 7.0% |
| 10 | $489.48 | 201 | $98K | 10.2% |
| 11 | $489.48 | 201 | $98K | 10.2% |
| 12 | $491.65 | 70 | $34K | 3.6% |
| 13 | $492.45 | 134 | $66K | 6.9% |
| 14 | $492.45 | 134 | $66K | 6.9% |
| 15 | $493.24 | 174 | $86K | 8.9% |
| 16 | $493.24 | 174 | $86K | 8.9% |
| 17 | $494.16 | 37 | $18K | 1.9% |
| 18 | $497.99 | 68 | $34K | 3.5% |
| Total | $488.94 avg | 1,970 | $963K | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $4.2M | — | Filing → |
| REGN | SELL | 2023-12-26 | $3.3M | — | Filing → |
| REGN | SELL | 2023-03-27 | $3.5M | — | Filing → |